0
Letters |

Multidisciplinary Approaches to Biomedical Research

Adam T. Perzynski, PhD
JAMA. 2010;304(20):2243-2244. doi:10.1001/jama.2010.1703
Text Size: A A A
Published online

To the Editor: In their Commentary on a new policy framework for the biomedical research enterprise, Drs Federoff and Rubin1 argued persuasively for reforms that could rid the research enterprise of boom-bust cycles, close funding gaps, and depoliticize interest group–driven funding decisions. The authors called for a coherent and inclusive policy advisory system that would have the support of policy makers and professional societies alike.

However, conspicuously absent from their vision of reform was any mention of the behavioral and social sciences. Anthropologists, economists, psychologists, and sociologists are as vital to a new framework for health research as their colleagues in biology, chemistry, engineering, and medicine. In 1983, Wilson described the pathway to discovery as proceeding through disciplinary consilience, stating that “Only fluency across the boundaries will provide a clear view of the world as it really is.”2

Medicine has a rich and continually developing tradition of interdisciplinary collaboration. In 1977, Engel introduced the biopsychosocial model, advocating for seeing the human body, the processes that determine health and disease, and the research enterprise from multiple scientific perspectives.3 From the early 1990s through the present, excitement over technological advancements in genomics, imaging, and other areas seems to have tempered enthusiasm in some constituencies for the importance of social and behavioral determinants of health. However, the understanding of molecular and genomic processes is incomplete without consideration of social, psychological, behavioral, and economic influences on health and disease.4 5

Although strides have likewise been made toward a more translational medicine, key biomedical innovations may be trapped between bench and bedside. Even after innovations reach the clinic, many of the most effective medications may be rendered useless when behavioral and social barriers prevent a patient from using them.

A new policy framework should harness the potential of the full range of scientists working to advance health, rather than confine itself only to the life sciences and physical sciences.

AUTHOR INFORMATION

Financial Disclosures: None reported.

REFERENCES

Federoff HJ, Rubin ER. A new research and development policy framework for the biomedical research enterprise.  JAMA. 2010;304(9):1003-1004
PubMed
Wilson EO. Consilience: The Unity of Knowledge. New York, NY: Alfred A Knopf Inc; 1998:13
Engel GL. The need for a new medical model: a challenge for biomedicine.  Science. 1977;196(4286):129-136
PubMed
Adler RH. Engel's biopsychosocial model is still relevant today.  J Psychosom Res. 2009;67(6):607-611
PubMed
Frankel R, ed, Quill T, ed, McDaniel S, edThe Biopsychosocial Approach: Past, Present, Future. Rochester, NY: University of Rochester Press; 2003

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Federoff HJ, Rubin ER. A new research and development policy framework for the biomedical research enterprise.  JAMA. 2010;304(9):1003-1004
PubMed
Wilson EO. Consilience: The Unity of Knowledge. New York, NY: Alfred A Knopf Inc; 1998:13
Engel GL. The need for a new medical model: a challenge for biomedicine.  Science. 1977;196(4286):129-136
PubMed
Adler RH. Engel's biopsychosocial model is still relevant today.  J Psychosom Res. 2009;67(6):607-611
PubMed
Frankel R, ed, Quill T, ed, McDaniel S, edThe Biopsychosocial Approach: Past, Present, Future. Rochester, NY: University of Rochester Press; 2003
November 24, 2010
Howard J. Federoff, MD, PhD; Elaine R. Rubin, PhD
JAMA. 2010;304(20):2243-2244.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.